Finalist
ImmuKNOWLEDGEy: Advancing Immunology in Multiple Sclerosis (MS)
by Lucid Group for Sanofi
Summary of work
Traditional MSL training models focus on a top-down approach, lacking experiences, interaction, and true clinical significance. Sanofi’s ‘ImmuKNOWLEDGEy’ programme designed and piloted a novel framework, to improve MSL understanding in neuroimmunology delivered via a creative, digital narrative. This curriculum also aimed to enhance the clinical applicability of Sanofi training models to elevate patient care, with ‘Jessie’s’ autobiographical patient experience of MS at its heart.
Collaboration with Sanofi was crucial to developing a meaningful, educational programme. Through iterative co-creation and combining MSL insights on preferred digital models and industry best practice for creating interactive learning environments, we piloted a podcast-focused, online training curriculum, chaptered by various stages of ‘Jessie’s’ journey.
Over 46 MSLs completed the curriculum, with 100% attendance and engagement across all channels. 85% rated the usefulness of the in-depth scientific training at least 8/10 for improving their understanding of a detailed neuroimmunology lecture. 95% rated training applicability to optimise fieldwork at least 8/10. Real-world impact of our model will become more evident following the pilot, as this curriculum is rolled out across Sanofi. ImmuKNOWLEDGEy has established a greater passion and confidence in MSLs for neuroimmunology, which has translated into meaningful engagements with key stakeholders to ultimately improve patient care.
Judges’ comments
Lucid Group and Sanofi have created an effective programme that moved the needle in how people think about MS. The pre-programme insights were incredibly detailed and the team really got under the skin of what it needed to do. The supporting materials were great and the platform was beautifully designed. An extensive and serious piece of work.
